<?xml version="1.0" encoding="UTF-8"?>
<p>CMV carriage was also associated with a significant reduction in vaccine-specific T cell responses (measured by IFN-γ ELISPOT) in the UK cohort (
 <xref ref-type="fig" rid="fig1">Fig. 1, E and F</xref>; P = 0.007). However, there was no significant difference in vaccine-specific T cell responses between either the UK CMV
 <sup>−</sup> or the CMV
 <sup>+</sup> group and the Senegalese cohort.
</p>
